Chronic Obstructive Pulmonary Disease (COPD) Nutrition Support Trial
NCT00538200 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 85
Last updated 2014-12-08
Summary
The purpose of this study is to determine the best form of dietary intervention to undernourished individuals with COPD.
The research aims to test the null hypothesis that there is no difference between oral nutritional supplements and dietary advice.
Conditions
- Malnutrition
Interventions
- DIETARY_SUPPLEMENT
-
Oral Nutritional Supplements (Fortisip)
These products are classified as non-medicinal, borderline substances, foods for special medical purposes. A range of commercially available liquid oral nutritional supplements (Fortisip) will be offered daily for a 3 month period.
- OTHER
-
Dietary Advice
Standard dietary advice
Sponsors & Collaborators
-
University Hospital Southampton NHS Foundation Trust
collaborator OTHER -
University of Southampton
lead OTHER
Principal Investigators
-
Marinos Elia, Professor · University of Southampton
Study Design
- Allocation
- RANDOMIZED
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-01-31
- Primary Completion
- 2011-09-30
- Completion
- 2011-09-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
Study of Effect of CSJ117 on Symptoms, Pharmacodynamics and Safety in Patients With COPD
NCT04882124 ·Status: COMPLETED ·Phase: PHASE2
-
Study in Patients With COPD
NCT00215423 ·Status: COMPLETED ·Phase: PHASE2
-
Study in Patients With COPD
NCT00215384 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of a Food Supplement on Quality of Life in Patients With Chronic Obstructive Pulmonary Disease.
NCT04815499 ·Status: COMPLETED ·Phase: NA
-
Long-term Oxygen Treatment Trial
NCT00692198 ·Status: COMPLETED ·Phase: PHASE3
-
Simvastatin in Chronic Obstructive Pulmonary Disease (COPD)
NCT00680641 ·Status: UNKNOWN ·Phase: PHASE4
-
Study in Patients With COPD
NCT00215449 ·Status: COMPLETED ·Phase: PHASE3
-
Investigate the Safety, Tolerability and Pharmacokinetics of CHF6523 in Healthy and in COPD Subjects
NCT04032535 ·Status: COMPLETED ·Phase: PHASE1
-
Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD)
NCT04042168 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Study of MK0359 in Patients With Chronic Obstructive Pulmonary Disease (COPD)(0359-016)
NCT00482235 ·Status: COMPLETED ·Phase: PHASE2
-
Effect on Structural Changes in Airways, Measured by MSCT, of Twice Daily 60mg AZD9668 for 12 Weeks in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT01054170 ·Status: COMPLETED ·Phase: PHASE2
-
An Investigation of the Mechanism of Action of Seretide in Chronic Obstructive Pulmonary Disease
NCT00974805 ·Status: COMPLETED ·Phase: PHASE4
-
IMD-1041 Chronic Obstructive Pulmonary Disease: Proof of Concept (POC) Study
NCT00883584 ·Status: UNKNOWN ·Phase: PHASE2
-
Dose of Corticosteroids in COPD
NCT01742338 ·Status: TERMINATED ·Phase: PHASE4
-
Medication Adherence Research in COPD Patients
NCT03174704 ·Status: COMPLETED
-
Enhancement of in-Vitro GC Function in Patients With COPD
NCT00241631 ·Status: COMPLETED ·Phase: PHASE2
-
Safety And Efficacy Of UK-432,097 In Chronic Obstructive Pulmonary Disease.
NCT00430300 ·Status: TERMINATED ·Phase: PHASE2
-
Pilot Study of Safety and Tolerability of Nutrifriend Cachexia in COPD Cachexia
NCT02442908 ·Status: COMPLETED ·Phase: NA
-
Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease
NCT03414541 ·Status: COMPLETED ·Phase: PHASE2
-
COPD on Primary Care Treatment (COOPT)
NCT00184977 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Statins in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT01151306 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Outcome of Corticosteroids in the Treatment of COPD Exacerbations in China
NCT03633838 ·Status: COMPLETED
-
Efficacy and Safety of Two Doses of Formoterol Fumarate MDI (PT005) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD), Compared to Foradil® Aerolizer® as an Active Control
NCT01043601 ·Status: WITHDRAWN ·Phase: PHASE2
-
Association of COPD Maintenance Medication Adherence With Resource Use and Cost Among COPD Patients
NCT03359122 ·Status: COMPLETED
-
A Study To Investigate The Effects Of GW856553 On Patients With COPD (Chronic Obstructive Pulmonary Disease)
NCT00392587 ·Status: COMPLETED ·Phase: PHASE2